Ameriprise Financial Inc Anika Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 25,430 shares of ANIK stock, worth $431,547. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,430

Previous 31,321 18.81%

Holding current value

$431,547

Previous $793,000 20.81%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$24.25 - $28.75 $142,856 - $169,366	-5,891 Reduced 18.81%	25,430 $628,000
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $201,547 - $233,539	-8,203 Reduced 20.75%	31,321 $793,000
Q1 2024 May 15, 2024	SELL	$21.95 - $26.42 $1.83 Million - $2.21 Million	-83,571 Reduced 67.89%	39,524 $1 Million
Q4 2023 Feb 14, 2024	SELL	$18.47 - $23.3 $2.24 Million - $2.83 Million	-121,418 Reduced 49.66%	123,095 $2.79 Million
Q3 2023 Nov 14, 2023	SELL	$16.98 - $26.1 $815,922 - $1.25 Million	-48,052 Reduced 16.42%	244,513 $4.56 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $2.12 Million - $2.43 Million	84,364 Added 40.52%	292,565 $7.6 Million
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $680,344 - $842,881	26,258 Added 14.43%	208,201 $5.98 Million
Q4 2022 Feb 14, 2023	SELL	$23.85 - $31.91 $224,595 - $300,496	-9,417 Reduced 4.92%	181,943 $5.39 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $469,431 - $532,915	-21,593 Reduced 10.14%	191,360 $4.56 Million
Q2 2022 Aug 15, 2022	SELL	$20.4 - $25.53 $100,531 - $125,811	-4,928 Reduced 2.26%	212,953 $4.75 Million
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $19 Million - $28.1 Million	-769,767 Reduced 77.94%	217,881 $5.47 Million
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $261,881 - $329,124	-7,309 Reduced 0.73%	987,648 $35.4 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $85,831 - $98,501	-2,215 Reduced 0.22%	994,957 $42.3 Million
Q2 2021 Aug 16, 2021	SELL	$39.42 - $48.08 $7,213 - $8,798	-183 Reduced 0.02%	997,172 $43.2 Million
Q1 2021 May 17, 2021	SELL	$32.49 - $45.96 $219,404 - $310,367	-6,753 Reduced 0.67%	997,355 $40.7 Million
Q4 2020 Feb 12, 2021	SELL	$32.59 - $45.26 $92,262 - $128,131	-2,831 Reduced 0.28%	1,004,108 $45.4 Million
Q3 2020 Nov 16, 2020	BUY	$32.56 - $38.57 $3.05 Million - $3.61 Million	93,574 Added 10.24%	1,006,939 $35.6 Million
Q2 2020 Aug 14, 2020	BUY	$27.83 - $37.73 $7.49 Million - $10.2 Million	269,074 Added 41.76%	913,365 $34.5 Million
Q1 2020 May 15, 2020	BUY	$22.38 - $54.06 $1.49 Million - $3.59 Million	66,403 Added 11.49%	644,291 $18.6 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $3.51 Million - $4.97 Million	-67,695 Reduced 10.49%	577,888 $30 Million
Q3 2019 Nov 14, 2019	SELL	$40.05 - $57.47 $14.2 Million - $20.4 Million	-355,496 Reduced 35.51%	645,583 $35.4 Million
Q2 2019 Aug 14, 2019	BUY	$30.3 - $41.14 $10.8 Million - $14.7 Million	356,686 Added 55.35%	1,001,079 $40.7 Million
Q1 2019 May 15, 2019	BUY	$29.37 - $40.49 $12.9 Million - $17.8 Million	438,849 Added 213.51%	644,393 $19.5 Million
Q4 2018 Feb 14, 2019	BUY	$30.16 - $43.0 $141,963 - $202,401	4,707 Added 2.34%	205,544 $6.91 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $78,824 - $102,066	2,401 Added 1.21%	200,837 $8.47 Million
Q2 2018 Aug 14, 2018	SELL	$28.77 - $48.27 $4.21 Million - $7.06 Million	-146,311 Reduced 42.44%	198,436 $6.35 Million
Q1 2018 May 15, 2018	BUY	$49.22 - $68.43 $11.2 Million - $15.6 Million	228,253 Added 195.94%	344,747 $17.1 Million
Q4 2017 Feb 12, 2018	SELL	$52.14 - $59.94 $141,560 - $162,737	-2,715 Reduced 2.28%	116,494 $6.28 Million
Q3 2017 Nov 07, 2017	BUY	$51.16 - $58.21 $6.1 Million - $6.94 Million	119,209	119,209 $6.91 Million

Others Institutions Holding ANIK

# of Institutions

123

Shares Held

11.5M

Call Options Held

200

Put Options Held

100

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $248M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Anika Therapeutics, Inc. Transaction History